Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor (Q42119720)
Jump to navigation
Jump to search
scientific article published on June 1, 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor |
scientific article published on June 1, 1992 |
Statements
1 reference
Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor (English)
Ford-Hutchinson AW
1 reference
Guévremont D
1 reference
C. Brideau
C. Chan
S. Charleson
D. Denis
J. F. Evans
A. W. Ford-Hutchinson
R. Fortin
J. W. Gillard
J. Guay
D. Guévremont
1 June 1992
1 reference
1 reference
70
1 reference
6
1 reference
799-807
1 reference
Identifiers
1 reference